Article

Urologists' interests at heart in patients' rights bill

On Thursday, August 2, 2001, the House of Representatives finally passed its version of the "Patients' Bill of Rights"-one that contains a cap on monetary awards to patients found to have been injured by an HMO's actions. First, I would like to reiterate that the AUA's top priority is a patient protection bill that will work and be signed by the president. AUA has been working to this end for the past 6 years, since joining the Patient Access Coalition. I can assure you that all of the recent bills-conservative and liberal-now contain the following principles long advocated by AUA:

Related Videos
3d rendered illustration - bladder cancer | Image Credit: © Sebastian Kaulitzki - stock.adobe.com
Landon Trost, MD, answers a question during a Zoom video interview
Anna Myers, CNP, answers a question during a Zoom video interview
Dr Louise Kostos answers a question during a Zoom video interview
1 expert in this video
Perry Xu, MD, answers a question during a Zoom video interview
Helen L. Bernie, DO, MPH, answers a question during a Zoom video interview
Related Content
Cretostimogene grenadenorepvec continues to show favorable efficacy, safety in NMIBC
March 25th 2025

Cretostimogene grenadenorepvec continues to show favorable efficacy, safety in NMIBC

Hannah Clarke
"Now with the new translational data indicating that post-treatment close contact precautions are unnecessary, I am confident that cretostimogene will represent a breakthrough in bladder cancer treatment, if approved by the FDA," says Trinity J. Bivalacqua, MD, PhD.
Episode 4 Video: Moving Toward a Patient-Centered Approach in NMIBC Management
March 3rd 2025

Episode 4 Video: Moving Toward a Patient-Centered Approach in NMIBC Management

Max Kates, MD Neal Shore, MD, FACS Katie S. Murray, DO, MS
Panelists discuss the impact of long-term care in patients with non–muscle-invasive bladder cancer (NMIBC), considering the unique needs of specific patient groups and highlighting advancements in NMIBC treatment that may support better care experiences for patients.
Additional NIAGARA data reinforce benefit of perioperative durvalumab in MIBC
March 24th 2025

Additional NIAGARA data reinforce benefit of perioperative durvalumab in MIBC

Hannah Clarke
“The addition of the durvalumab did not make treatment more morbid than chemotherapy alone, and it didn't change or increase the surgical complications you saw in the ward," says James W.F. Catto, MBChB, PhD, FRCS.
Episode 4 Podcast: Moving Toward a Patient-Centered Approach in NMIBC Management
February 21st 2025

Episode 4 Podcast: Moving Toward a Patient-Centered Approach in NMIBC Management

Max Kates, MD Neal Shore, MD, FACS Katie S. Murray, DO, MS
Panelists discuss the impact of long-term care in patients with non–muscle-invasive bladder cancer (NMIBC), considering the unique needs of specific patient groups and highlighting advancements in NMIBC treatment that may support better care experiences for patients.
Avoidance of prostate cancer screening linked to increased risk of PCSM
March 21st 2025

Avoidance of prostate cancer screening linked to increased risk of PCSM

Hannah Clarke
“Our study identifies that men who were invited for screening, but do not attend screening appointments are at significantly higher risk of dying from prostate cancer compared to men who were not offered screening or accepted an invitation for screening,” says Renée Leenen MD.
FDA reports Urgent Device Field Correction notice for CVAC Aspiration System
March 21st 2025

FDA reports Urgent Device Field Correction notice for CVAC Aspiration System

Hannah Clarke
Calyxo has identified a new risk of injury when the CVAC System is used in patients with high viscosity fluid in their kidneys at the start of the procedure.
© 2025 MJH Life Sciences

All rights reserved.